Proteomics reveals urine apolipoprotein A‑I as a potential biomarker of acute kidney injury following percutaneous coronary intervention in elderly patients

Zhou,Fangfang; Zhou,Fangfang; Zhou,Fangfang; Zhou,Fangfang; Zhou,Fangfang; Zhou,Fangfang; Luo,Qun; Luo,Qun; Luo,Qun; Luo,Qun; Luo,Qun; Luo,Qun; Han,Lina; Han,Lina; Han,Lina; Han,Lina; Han,Lina; Han,Lina; Shen,Gen; Shen,Gen; Shen,Gen; Shen,Gen; Shen,Gen; Shen,Gen; Huang,Lulu; Huang,Lulu; Huang,Lulu; Huang,Lulu; Huang,Lulu; Huang,Lulu; Ye,Honghua; Ye,Honghua; Ye,Honghua; Ye,Honghua; Ye,Honghua; Ye,Honghua

doi:10.3892/etm.2021.10177

Proteomics reveals urine apolipoprotein A‑I as a potential biomarker of acute kidney injury following percutaneous coronary intervention in elderly patients

Authors:
- Fangfang Zhou
- Qun Luo
- Lina Han
- Gen Shen
- Lulu Huang
- Honghua Ye
View Affiliations

Affiliations: Department of Nephrology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China, Department of Cardiology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China
Published online on: May 11, 2021 https://doi.org/10.3892/etm.2021.10177
Article Number: 745
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate how changes in the lipid composition are involved in early stages of acute kidney injury (AKI) following percutaneous coronary intervention (PCI‑AKI) in elderly patients. A prospective nested case‑control study was performed. Alterations in the urine protein accumulation were investigated in patients with and without PCI‑AKI using isobaric tags for relative and absolute quantitation (iTRAQ). In addition, differentially expressed proteins (DEPs) related to lipids were confirmed using parallel reaction monitoring (PRM)‑based targeted proteomics. From the cohort of elderly patients (>60 years of age), 14 (12.28%) developed AKI within 48 h after PCI. No significant differences were detected between the AKI and control (CON) groups for serum creatinine at 24 h following treatment (P=0.27). Among the DEPs that overlapped in both the AKI‑24 h/AKI‑Pre (AKI group at 24 h post‑PCI vs. pre‑PCI) and AKI‑24 h/CON‑24 h groups (AKI group vs. CON group at 24 h post‑PCI), only apolipoprotein A‑I (apoA‑I) was related to lipids, which displayed a significant upregulation in expression levels. The protein expression levels of apoA‑I displayed a 5.98‑fold increase at 24 h after PCI from the baseline and a 2.09‑fold increase compared with the control group as determined using PRM, which exhibited a similar trend to the iTRAQ results. Using protein‑protein interaction analyses, apoA‑I was determined to be functionally linked to the complement and coagulation cascades, the renin‑angiotensin system and the hypoxia‑inducible factor‑1 signaling pathway. Using the pathway analysis tool from the Kyoto Encyclopedia of Genes and Genomes, several pathways were identified to be associated with apoA‑I, including fat digestion and absorption, vitamin digestion and absorption, as well as the peroxisome proliferator activated receptor signaling pathway. In conclusion, apoA‑I may be a promising biomarker for the early diagnosis of PCI‑AKI in elderly patients. The role of apoA‑I in the pathobiology of PCI‑AKI requires further exploration.

View Figures

View References

1	Ozkok S and Ozkok A: Contrast-induced acute kidney injury, A review of practical points. World J Nephrol. 6:86–99. 2017.PubMed/NCBI View Article : Google Scholar
2	Chalikias G, Drosos I and Tziakas DN: Prevention of contrast-induced acute kidney injury: An update. Cardiovasc Drugs Ther. 30:215–228. 2016.PubMed/NCBI View Article : Google Scholar
3	Fähling M, Seeliger E, Patzak A and Persson PB: Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol. 13:169–180. 2017.PubMed/NCBI View Article : Google Scholar
4	McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC and Mehta A: Contrast-induced acute kidney injury. J Am Coll Cardiol. 68:1465–1473. 2016.PubMed/NCBI View Article : Google Scholar
5	Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, Spandidos DA, Tsitsimpikou C and Tsatsakis A: Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 180:99–112. 2017.PubMed/NCBI View Article : Google Scholar
6	Andreucci M, Faga T, Riccio E, Sabbatini M, Pisani A and Michael A: The potential use of biomarkers in predicting contrast-induced acute kidney injury. Int J Nephrol Renovasc Dis. 9:205–221. 2016.PubMed/NCBI View Article : Google Scholar
7	Luo Q, Zhou F, Dong H, Wu L, Chai L, Lan K and Wu M: Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention. Clin Nephrol. 79:85–92. 2013.PubMed/NCBI View Article : Google Scholar
8	De Loor J, Gevaert K, Hoste E and Meyer E: How has urinary proteomics contributed to the discovery of early biomarkers of acute kidney injury? Expert Rev Proteomics. 11:415–424. 2014.PubMed/NCBI View Article : Google Scholar
9	Sigdel TK, Gao Y, He J, Wang A, Nicora CD, Fillmore TL, Shi T, Webb-Robertson BJ, Smith RD, Qian WJ, et al: Mining the human urine proteome for monitoring renal transplant injury. Kidney Int. 89:1244–1252. 2016.PubMed/NCBI View Article : Google Scholar
10	Luczak M, Formanowicz D, Marczak Ł, Suszyńska-Zajczyk J, Pawliczak E, Wanic-Kossowska M and Stobiecki M: iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis. Sci Rep. 6(32511)2016.PubMed/NCBI View Article : Google Scholar
11	Rao S, Walters KB, Wilson L, Chen B, Bolisetty S, Graves D, Barnes S, Agarwal A and Kabarowski JH: Early lipid changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging. Am J Physiol Renal Physiol. 310:F1136–F1147. 2016.PubMed/NCBI View Article : Google Scholar
12	Park HS, Kim CJ, Hwang BH, Kim TH, Koh YS, Park HJ, Her SH, Jang SW, Park CS, Lee JM, et al: HDL cholesterol level is associated with contrast induced acute kidney injury in chronic kidney disease patients undergoing PCI. Sci Rep. 6(35774)2016.PubMed/NCBI View Article : Google Scholar
13	Smith LE, Smith DK, Blume JD, Linton MF and Billings FT IV: High-Density Lipoprotein cholesterol concentration and acute kidney injury after cardiac surgery. J Am Heart Assoc. 6(e006975)2017.PubMed/NCBI View Article : Google Scholar
14	Shi T, Song E, Nie S, Rodland KD, Liu T, Qian WJ and Smith RD: Advances in targeted proteomics and applications to biomedical research. Proteomics. 16:2160–2182. 2016.PubMed/NCBI View Article : Google Scholar
15	Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2:1–138. 2012.
16	Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al: A new equation to estimate glomerular fltration rate. Ann Intern Med. 150:604–612. 2009.PubMed/NCBI View Article : Google Scholar
17	Michael H, Justin D and Virginia E: Current state of the art for enhancing urine biomarker discovery. Expert Rev Proteomics. 13:609–626. 2016.PubMed/NCBI View Article : Google Scholar
18	Chen Y, Mao P and Wang D: Quantitation of intact proteins in human plasma using top-down parallel reaction monitoring-MS. Anal Chem. 90:10650–10653. 2018.PubMed/NCBI View Article : Google Scholar
19	Andreucci M, Faga T, Pisani A, Sabbatini M and Michael A: Acute kidney injury by radiographic contrast media: Pathogenesis and prevention. Biomed Res Int. 2014(362725)2014.PubMed/NCBI View Article : Google Scholar
20	Moreira RS, Irigoyen M, Sanches TR, Volpini RA, Camara NO, Malheiros DM, Shimizu MH, Seguro AC and Andrade L: Apolipoprotein A-I mimetic peptide 4F attenuates kidney injury, heart injury, and endothelial dysfunction in sepsis. Am J Physiol Regul Integr Comp Physiol. 307:R514–R524. 2014.PubMed/NCBI View Article : Google Scholar
21	Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, Stewart KN, Cuzzocrea S, Britti D, Mota-Filipe H and Chatterjee PK: High density lipoprotein (HDL) reduces renal schemia/reperfusion injury. J Am Soc Nephrol. 14:1833–1843. 2003.PubMed/NCBI View Article : Google Scholar
22	Li Y, Dong JB and Wu MP: Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol. 590:417–422. 2008.PubMed/NCBI View Article : Google Scholar
23	van der Vorst EPC: High-density lipoproteins and apolipoprotein A1. Subcell Biochem. 94:399–420. 2020.PubMed/NCBI View Article : Google Scholar
24	Tanaka S, Couret D, Tran-Dinh A, Duranteau J, Montravers P, Schwendeman A and Meilhac O: High-density lipoproteins during sepsis: From bench to bedside. Crit Care. 24(134)2020.PubMed/NCBI View Article : Google Scholar